SB435Introduced in the Senate
Public Health - Medetomidine and Xylazine Consumer Protection Act
Introduced by William Folden, District 4
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.
Where it stands
Motion Laid Over (Senator Ready) Adopted
April 13, 2026
How did lawmakers vote?
No recorded vote is available for this bill yet.
Bill history
First Reading Finance
Hearing 2/11 at 2:00 p.m.
Favorable with Amendments Report by Finance
Favorable with Amendments {983727/1
Motion Laid Over (Senator Ready) Adopted
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.